Cited by 26MicroRNA in disease regulationGene expression and cancer classificationArtificial Intelligence in Healthcare

Unlocking the potential of microRNAs: Machine learning identifies key biomarkers for myocardial infarction diagnosis

Open access
Samadishadlou, Mehrdad, Rahbarghazi, Reza, Piryaei, Zeynab, Esmaeili, Mahdad, Avcı, Çığır Biray, Bani, Farhad, Kavousi, Kaveh·2023·Cardiovascular Diabetology

Abstract

Background: MicroRNAs (miRNAs) play a crucial role in regulating adaptive and maladaptive responses in cardiovascular diseases, making them attractive targets for potential biomarkers. However, their potential as novel biomarkers for diagnosing cardiovascular diseases requires systematic evaluation. Methods: In this study, we aimed to identify a key set of miRNA biomarkers using integrated bioinformatics and machine learning analysis. We combined and analyzed three gene expression datasets from the Gene Expression Omnibus (GEO) database, which contains peripheral blood mononuclear cell (PBMC) samples from individuals with myocardial infarction (MI), stable coronary artery disease (CAD), and healthy individuals. Additionally, we selected a set of miRNAs based on their area under the receiver operating characteristic curve (AUC-ROC) for separating the CAD and MI samples. We designed a two-layer architecture for sample classification, in which the first layer isolates healthy samples from unhealthy samples, and the second layer classifies stable CAD and MI samples. We trained different machine learning models using both biomarker sets and evaluated their performance on a test set. Results: We identified hsa-miR-21-3p, hsa-miR-186-5p, and hsa-miR-32-3p as the differentially expressed miRNAs, and a set including hsa-miR-186-5p, hsa-miR-21-3p, hsa-miR-197-5p, hsa-miR-29a-5p, and hsa-miR-296-5p as the optimum set of miRNAs selected by their AUC-ROC. Both biomarker sets could distinguish healthy from not-healthy samples with complete accuracy. The best performance for the classification of CAD and MI was achieved with an SVM model trained using the biomarker set selected by AUC-ROC, with an AUC-ROC of 0.96 and an accuracy of 0.94 on the test data. Conclusions: Our study demonstrated that miRNA signatures derived from PBMCs could serve as valuable novel biomarkers for cardiovascular diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12933-023-01957-7

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [20]Wickham H Ggplot2: elegant graphics for data analysis 2016 New York Springer

Cited by

Sorted by citations

Authors
Samadishadlou, M., Rahbarghazi, R., Piryaei, Z., Esmaeili, M., Avcı, Ç. B., Bani, F., & Kavousi, K.
Affiliations
  • Tabriz University of Medical Sciences (IR)
  • University of Tehran (IR)
  • Ege University (TR)
Corresponding author
  • Bani, Farhad
  • Kavousi, Kaveh
Venue
Cardiovascular Diabetology
Published
2023-09-11
Volume
22
Issue
1
Pages
247-247
ISSN
1475-2840 (ISSN-L)
OpenAlex
W4386599689
Cited by
26
References
44
Citations by year
2026: 9 · 2025: 10 · 2024: 7
FWCI
3.30
Type
journal article
Language
en
Open access
Locations
  • Cardiovascular Diabetology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Tabriz University of Medical Sciences (66372)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
Keywords
microRNA, myocardial infarction, biomarkers, stable coronary artery disease, peripheral blood mononuclear cells, microRNA signature, cardiovascular disease diagnosis, support vector machine classification
MeSH terms
Machine Learning, Coronary Artery Disease, Humans, Leukocytes, Mononuclear, Myocardial Infarction, Biomarkers, MicroRNAs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review